Tuesday, September 11, 2012 PEDDLING of illegal drugs in Davao City is becoming a family affair, the Philippine Drug Enforcement Agency (PDEA) regional chief said in explaining why there is an increase in illegal drug activities. Meaning not only the father ang involved sa drug rate kasama na rin ang kanila mga asawa o anak (Its a family affair business in which the wife and the children are also involved, not only the father), said Emerson Rosales, PDEA regional director. Check our new look and tell us what you think. He said the authorities have monitored this based on the previous arrests of drug violators. He said it is never enough to just constrict the supply as the city has done to some extent, but there has to be effective actions to reduce the demand. Ang supply reduction sa pag aresto ng mga drug offenders ay isa lamang solution sa drug problem but the demand transaction problem ay kasamang solution din sa pag-solve dito sa drugs (The supply reduction is just one of the solutions but the demand transaction problem is also a way to solve drugs issue), he said. He said the solution to the drug situation problem does … Continue reading →

Javier Sicilia leads a 50-cross procession at Loyola Marymount University, each cross representing 1,000 cartel murder victims. STORY HIGHLIGHTS Editor's note: Javier Sicilia is one of Mexico's most highly regarded poets and the leader of the Movement for Peace with Justice and Dignity. His son, Juan Francisco, was murdered last year near his hometown of Cuernavaca. The Movement's Caravan for Peace crossed the border at San Diego on August 12 and will arrive in Washington on September 10. Follow on Twitter @caravanaUSA (CNN) -- Why was my son murdered? He was 24, and he had never tried drugs. He didn't even smoke. He had paid half his university costs with a sports scholarship and was working as administrative staff at a cardiac clinic in Morelos, Mexico. Why then was my son suffocated by hit men from the Gulf Cartel? Why did his six friends, just like him, die at his side? The answer, you may tell me, is obvious. "Because drug traffickers are bad, and must be stopped." The answer, however, is not that simple. If it were I would not be leading a caravan for peace across the United States. Let's pose the question differently. If Mexico's President Felipe … Continue reading →

ByMyHealthNewsDaily Staff Some drugs that treat high blood pressure may increase the risk of lip cancer, a new study suggests. In the study, people who took thehigh blood pressuredrug hydrochlorothiazide for five years or more were four times more likely to develop lip cancer, compared with those who did not take the drug. The study included only Caucasian people. Hydrochlorothiazide is a photosensitizing drug, meaning it can increase a person's sensitivity to sunlight. People who take photosensitizing drugs may burn more easily, or develop rashes upon sunlight exposure. Previous studies have linked hydrochlorothiazide and an increased risk of certainskin cancers. Other photosensitizing drugs examined in the study, including one called nifedipine, increased the risk of lip cancer more than twofold in whites. The findings held even after the researchers took into account study participants' smoking, a factor that increases the risk of lip cancer. Lip cancer is rare (there are about 0.7 cases per 100,000 people per year in the United States), and the benefits of high blood pressure drugs generally outweigh the increased risk of this particular cancer, the researchers said. "However, physicians prescribing photosensitizing drugs should ascertain whether patients are at high risk of lip cancer because of … Continue reading →

NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Ovarian Cancer Drugs Market 2011-2015 http://www.reportlinker.com/p0962688/Global-Ovarian-Cancer-Drugs-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication TechNavio's analysts forecast the Global Ovarian Cancer Drugs market to grow at a CAGR of 13.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of ovarian cancer. The Global Ovarian Cancer Drugs market has also been witnessing the trend of the use of combination therapies for the treatment of ovarian cancer. However, patent expiration of key drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Ovarian Cancer Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include Eli Lilly and Co., GlaxoSmithKline plc, Bristol Myers Squibb Co., and Roche Pharmaceuticals. Other vendors mentioned in the report are Johnson & Johnson, Amgen … Continue reading →